Literature DB >> 22581100

Molecular mechanism of the enhanced virulence of 2009 pandemic influenza A (H1N1) virus from D222G mutation in the hemagglutinin: a molecular modeling study.

Dabo Pan1, Weihua Xue, Xiaoting Wang, Jingjing Guo, Huanxiang Liu, Xiaojun Yao.   

Abstract

D222G mutation of the hemagglutinin (HA) is of special interest because of its close association with the enhanced virulence of 2009 pandemic influenza A (H1N1) virus through the increased binding affinity to α2,3-linked sialylated glycan receptors. However, there is still a lack of detailed understanding about the molecular mechanism of this enhanced virulence. Here, molecular dynamics simulation and binding free energy calculation were performed to explore the altered glycan receptor binding mechanism of HA upon the D222G mutation by studying the interaction of one α2,3-linked sialylglycan (sequence: SIA-GAL-NAG) with the wild type and D222G mutated HA. The binding free energy calculation based on the molecular mechanics generalized Born surface area (MM-GBSA) method indicates that the D222G mutated HA has a much stronger binding affinity with the studied α2,3-linked glycan than the wild type. This is consistent with the experimental result. The increased binding free energy of D222G mutant mainly comes from the increased energy contribution of Gln223. The structural analysis proves that the altered electrostatic potential of receptor binding domain (RBD) and the increased flexibility of 220-loop are the essential reasons leading to the increased affinity of HA to α2,3-linked sialic acid glycans. The obtained results of this study have allowed a deeper understanding of the receptor recognition mechanism and the pathogenicity of influenza virus, which will be valuable to the structure-based inhibitors design targeting influenza virus entry process.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22581100     DOI: 10.1007/s00894-012-1423-2

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  31 in total

1.  Molecular dynamics and free-energy calculations applied to affinity maturation in antibody 48G7.

Authors:  L T Chong; Y Duan; L Wang; I Massova; P A Kollman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

2.  Structural characterization of the hemagglutinin receptor specificity from the 2009 H1N1 influenza pandemic.

Authors:  Rui Xu; Ryan McBride; Corwin M Nycholat; James C Paulson; Ian A Wilson
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

3.  The Amber biomolecular simulation programs.

Authors:  David A Case; Thomas E Cheatham; Tom Darden; Holger Gohlke; Ray Luo; Kenneth M Merz; Alexey Onufriev; Carlos Simmerling; Bing Wang; Robert J Woods
Journal:  J Comput Chem       Date:  2005-12       Impact factor: 3.376

4.  Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico.

Authors:  Rogelio Perez-Padilla; Daniela de la Rosa-Zamboni; Samuel Ponce de Leon; Mauricio Hernandez; Francisco Quiñones-Falconi; Edgar Bautista; Alejandra Ramirez-Venegas; Jorge Rojas-Serrano; Christopher E Ormsby; Ariel Corrales; Anjarath Higuera; Edgar Mondragon; Jose Angel Cordova-Villalobos
Journal:  N Engl J Med       Date:  2009-06-29       Impact factor: 91.245

5.  Clinical and virological course of infection with haemagglutinin D222G mutant strain of 2009 pandemic influenza A (H1N1) virus.

Authors:  Paul K S Chan; Nelson Lee; Gavin M Joynt; K W Choi; Jo L K Cheung; Apple C M Yeung; Philip Lam; Rity Wong; Bo-Wah Leung; Hing-Yu So; Wai-Yip Lam; David C S Hui
Journal:  J Clin Virol       Date:  2011-02-16       Impact factor: 3.168

6.  In silico identification of the potential drug resistance sites over 2009 influenza A (H1N1) virus neuraminidase.

Authors:  Huanxiang Liu; Xiaojun Yao; Chengqi Wang; Jian Han
Journal:  Mol Pharm       Date:  2010-06-07       Impact factor: 4.939

7.  Virulence-associated substitution D222G in the hemagglutinin of 2009 pandemic influenza A(H1N1) virus affects receptor binding.

Authors:  Salin Chutinimitkul; Sander Herfst; John Steel; Anice C Lowen; Jianqiang Ye; Debby van Riel; Eefje J A Schrauwen; Theo M Bestebroer; Björn Koel; David F Burke; Kyle H Sutherland-Cash; Chris S Whittleston; Colin A Russell; David J Wales; Derek J Smith; Marcel Jonges; Adam Meijer; Marion Koopmans; Guus F Rimmelzwaan; Thijs Kuiken; Albert D M E Osterhaus; Adolfo García-Sastre; Daniel R Perez; Ron A M Fouchier
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

8.  Structure and Receptor binding properties of a pandemic H1N1 virus hemagglutinin.

Authors:  Hua Yang; Paul Carney; James Stevens
Journal:  PLoS Curr       Date:  2010-03-22

9.  Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity.

Authors:  G N Rogers; J C Paulson; R S Daniels; J J Skehel; I A Wilson; D C Wiley
Journal:  Nature       Date:  1983 Jul 7-13       Impact factor: 49.962

10.  Mechanism of glycan receptor recognition and specificity switch for avian, swine, and human adapted influenza virus hemagglutinins: a molecular dynamics perspective.

Authors:  E Irene Newhouse; Dong Xu; Phineus R L Markwick; Rommie E Amaro; Hsing C Pao; Kevin J Wu; Maqsudul Alam; J Andrew McCammon; Wilfred W Li
Journal:  J Am Chem Soc       Date:  2009-12-02       Impact factor: 15.419

View more
  7 in total

1.  Reduction of Neuraminidase Activity Exacerbates Disease in 2009 Pandemic Influenza Virus-Infected Mice.

Authors:  Charlene Ranadheera; Mable W Hagan; Anders Leung; Brad Collignon; Todd Cutts; Steven Theriault; Carissa Embury-Hyatt; Darwyn Kobasa
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

2.  Emergence of HA mutants during influenza virus pneumonia.

Authors:  Maria Eugenia Vázquez Manríquez; Akiko Makino; Motoko Tanaka; Yasuhisa Abe; Hiroyuki Yoshida; Ichiro Morioka; Soichi Arakawa; Yasuhiro Takeshima; Kentaro Iwata; Jin Takasaki; Toshie Manabe; Takaaki Nakaya; Shota Nakamura; Anjarath Lorena Higuera Iglesias; Rosa Maria Rivera Rossales; Erika Pena Mirabal; Tateki Ito; Toshio Kitazawa; Teruaki Oka; Makoto Yamashita; Koichiro Kudo; Kyoko Shinya
Journal:  Int J Clin Exp Pathol       Date:  2012-10-01

3.  The mechanism of poly-galloyl-glucoses preventing Influenza A virus entry into host cells.

Authors:  Hu Ge; Ge Liu; Yang-Fei Xiang; Yu Wang; Chao-Wan Guo; Nan-Hao Chen; Ying-Jun Zhang; Yi-Fei Wang; Kaio Kitazato; Jun Xu
Journal:  PLoS One       Date:  2014-04-09       Impact factor: 3.240

4.  Molecular Characterisation of the Haemagglutinin Glycan-Binding Specificity of Egg-Adapted Vaccine Strains of the Pandemic 2009 H1N1 Swine Influenza A Virus.

Authors:  Vincenzo Carbone; Elena K Schneider; Steve Rockman; Mark Baker; Johnny X Huang; Chi Ong; Matthew A Cooper; Elizabeth Yuriev; Jian Li; Tony Velkov
Journal:  Molecules       Date:  2015-06-05       Impact factor: 4.411

5.  Targeting Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer by Inducing Epidermal Growth Factor Receptor Degradation via Methionine 790 Oxidation.

Authors:  Elaine Lai-Han Leung; Xing-Xing Fan; Maria Pik Wong; Zhi-Hong Jiang; Zhong-Qiu Liu; Xiao-Jun Yao; Lin-Lin Lu; Yan-Ling Zhou; Li-Fong Yau; Vicky Pui-Chi Tin; Liang Liu
Journal:  Antioxid Redox Signal       Date:  2015-12-14       Impact factor: 8.401

6.  Computational analysis of the receptor binding specificity of novel influenza A/H7N9 viruses.

Authors:  Xinrui Zhou; Jie Zheng; Fransiskus Xaverius Ivan; Rui Yin; Shoba Ranganathan; Vincent T K Chow; Chee-Keong Kwoh
Journal:  BMC Genomics       Date:  2018-05-09       Impact factor: 3.969

7.  Influenza A virus hemagglutinin mutations associated with use of neuraminidase inhibitors correlate with decreased inhibition by anti-influenza antibodies.

Authors:  Natalia A Ilyushina; Takashi E Komatsu; William L Ince; Eric F Donaldson; Nicolette Lee; Julian J O'Rear; Raymond P Donnelly
Journal:  Virol J       Date:  2019-11-29       Impact factor: 4.099

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.